FrancophonIA/ELRC3.0 huggingface dataset:
English: MBC patients with Grade ³ 3 and EBC patients with Grade ³ 2 peripheral neuropathy at baseline were excluded from clinical studies.
Croatian: Bolesnici s metastatskim rakom dojke koji su na početku ispitivanja imali perifernu neuropatiju stupnja ≥ 3 i bolesnici s ranim rakom dojke koji su na početku ispitivanja imali perifernu neuropatiju stupnja ≥ 2 nisu bili uključeni u klinička ispitivanja.
English: Do not administer trastuzumab emtansine until AST recovers to Grade £ 1, and then treat at the same dose level
Croatian: Trastuzumab emtanzin ne smije se primijeniti dok se AST ne vrati na vrijednost stupnja ≤ 1, a zatim liječenje treba nastaviti istom dozom.
English: Cases of haemorrhagic events, including central nervous system, respiratory and gastrointestinal haemorrhage, have been reported with trastuzumab emtansine treatment.
Croatian: Kod primjene trastuzumab emtanzina prijavljeni su slučajevi krvarenja, uključujući krvarenje u središnjem živčanom, dišnom i probavnom sustavu.
English: In order to prevent medicinal product errors it is important to check the vial labels to ensure that the medicinal product being prepared and administered is Kadcyla (trastuzumab emtansine) and not Herceptin (trastuzumab).
Croatian: U svrhu sprječavanja pogrešaka zamjene lijekova, važno je provjeriti naljepnicu na bočici kako biste bili sigurni da je lijek koji se priprema i primjenjuje Kadcyla (trastuzumab emtanzin), a ne Herceptin (trastuzumab).
English: It must not be administered as an intravenous push or bolus.
Croatian: Lijek se ne smije primijeniti brzom niti bolusnom intravenskom injekcijom.
English: The population PK analysis showed that age did not affect the PK of trastuzumab emtansine.
Croatian: Populacijska farmakokinetička analiza pokazala je da dob ne utječe na farmakokinetiku trastuzumab emtanzina.
English: Do not administer trastuzumab emtansine.
Croatian: Trastuzumab emtanzin ne smije se primijeniti.
English: Left ventricular dysfunction was reported in 2.2% of patients in MBC clinical studies with trastuzumab emtansine.
Croatian: U kliničkim ispitivanjima trastuzumab emtanzina kod metastatskog raka dojke disfunkcija lijeve klijetke prijavljena je u 2,2% bolesnika s metastatskim rakom dojke.
English: Dose Modifications for Patients with MBC Adverse reaction Severity
Croatian: Prilagodbe doze u bolesnika s metastatskim rakom dojke
English: The population PK analysis showed that race did not appear to influence the PK of trastuzumab emtansine.
Croatian: Na temelju populacijske farmakokinetičke analize čini se da rasa ne utječe na farmakokinetiku trastuzumab emtanzina.
English: Talk to your doctor or nurse before you are given Kadcyla if: · you have ever had a serious infusion-related reaction from using trastuzumab characterised by symptoms such as flushing, chills, fever, shortness of breath, difficulty breathing, rapid heartbeat or a drop in blood pressure.
Croatian: • ako ste ikada imali ozbiljnu reakciju povezanu s infuzijom zbog primjene trastuzumaba, koja se očituje simptomima poput navale crvenila, zimice, vrućice, nedostatka zraka, otežanog disanja,
English: (> 3.0 to ≤ 20´ ULN on day of scheduled treatment)
Croatian: Stupanj 2 - 3 (> 3,0 do ≤ 20 × GGN na dan kada je predviđena primjena terapije)
English: Serious, anaphylactic reactions have been observed in clinical studies with trastuzumab emtansine.
Croatian: U kliničkim ispitivanjima trastuzumab emtanzina primijećene su ozbiljne anafilaktičke reakcije.
English: Increased transaminases were reported in 24.2% of patients in MBC clinical studies.
Croatian: U kliničkim ispitivanjima kod metastatskog raka dojke povišene vrijednosti transaminaza prijavljene su u 24,2% bolesnika.
English: Do not administer trastuzumab emtansine until platelet count recovers to £ Grade 1 (≥ 75,000/mm3), and then reduce one dose level.
Croatian: Trastuzumab emtanzin ne smije se primijeniti dok se broj trombocita ne vrati na vrijednost stupnja ≤ 1 (≥ 75 000/mm3), a zatim dozu treba smanjiti za jednu razinu.
English: · Kadcyla 160mg: using a sterile syringe, slowly inject 8 mL of sterile water for injection into the
Croatian: • Kadcyla 160 mg: sterilnom štrcaljkom polako ubrizgajte 8 ml sterilne vode za injekcije u bočicu koja sadrži 160 mg trastuzumab emtanzina.
English: In the event of decreased platelet count to Grade 3 or greater (< 50,000/mm3), do not administer trastuzumab emtansine until platelet counts recover to Grade 1 (≥ 75,000/mm3) (see section 4.2).
Croatian: trastuzumab emtanzin ne smije se primijeniti dok se broj trombocita ne vrati na vrijednost stupnja 1 (≥ 75 000/mm3) (vidjeti dio 4.2).
English: Do not administer trastuzumab emtansine until platelet count recovers to £ Grade 1 (≥ 75,000/mm3), and then treat at the same dose level.
Croatian: Trastuzumab emtanzin ne smije se primijeniti dok se broj trombocita ne vrati na vrijednost stupnja ≤ 1 (≥ 75 000/mm3), a zatim liječenje treba nastaviti istom dozom.
English: (> 5 to ≤ 20´ ULN on day of scheduled treatment)
Croatian: Stupanj 3 (> 5 do ≤ 20 × GGN na dan kada je predviđena primjena terapije)
English: Hepatotoxicity, Hepatic failure, Nodular regenerative hyperplasia, Portal hypertension
Croatian: nodularna regenerativna hiperplazija,
English: Cases of bleeding events with a fatal outcome have been observed in both MBC and EBC.
Croatian: Zabilježeni su slučajevi krvarenja sa smrtnim ishodom i kod metastatskog i kod ranog raka dojke.
English: Injection site extravasation
Croatian: astenija periferni edem, zimica ekstravazacija na mjestu injekcije
English: Events of LVEF drop of >10% from baseline and/or CHF were observed in an observational study (BO39807) of MBC patients with baseline LVEF of 40-49% in a real world setting.
Croatian: U jednom opservacijskom ispitivanju (BO39807) liječenja u kliničkoj praksi provedenom u bolesnika s metastatskim rakom dojke kojima je početni LVEF iznosio 40 - 49% zabilježeni su događaji pada LVEF-a za > 10% od početne vrijednosti i/ili slučajevi kongestivnog zatajenja srca.
English: Epistaxis, Cough, Dyspnoea
Croatian: prsišta i sredoprsja epistaksa, kašalj,
English: Pneumonitis (ILD)
Croatian: dispneja pneumonitis (intersticijska bolest pluća)
English: Continue treatment with trastuzumab emtansine
Croatian: • Sažetak opisa svojstava lijeka Kadcyla (trastuzumab emtanzin)
English: How you are given Kadcyla
Croatian: Kako ćete primati lijek Kadcyla
English: Kadcyla, trastuzumab emtansine, is a HER2-targeted antibody-drug conjugate which contains the humanised anti-HER2 IgG1, trastuzumab, covalently linked to the microtubule inhibitor DM1 (a maytansine derivative) via the stable thioether linker MCC (4-[N-maleimidomethyl] cyclohexane-1-carboxylate).
Croatian: Kadcyla, trastuzumab emtanzin, je konjugat protutijela i lijeka koji ciljano djeluje na HER2, a sadrži trastuzumab, humanizirano IgG1 protutijelo za HER2, kovalentno vezano s inhibitorom mikrotubula
English: The majority of the patients (76.9%) had received an anthracycline-containing neoadjuvant chemotherapy regimen.19.5% percent of patients received another HER2-targeted agent in addition to trastuzumab as a component of neoadjuvant therapy; 93.8% of these patients received pertuzumab.
Croatian: Većina je bolesnika (76,9%) prethodno primala neoadjuvantni kemoterapijski protokol koji je sadržavao antraciklin.
English: Permanently discontinue trastuzumab emtansine
Croatian: Trajno obustaviti liječenje trastuzumab emtanzinom.
English: Tell your doctor or nurse straight away if you notice any of the side effects above.
Croatian: Odmah obavijestite liječnika ili medicinsku sestru ako primijetite neku od navedenih nuspojava.
English: NAME OF THE MEDICINAL PRODUCT Kadcyla 100 mg powder for concentrate for solution for infusion trastuzumab emtansine
Croatian: Kadcyla 100 mg prašak za koncentrat za otopinu za infuziju trastuzumab emtanzin
English: NAME OF THE MEDICINAL PRODUCT Kadcyla 160 mg powder for concentrate for solution for infusion trastuzumab emtansine
Croatian: Kadcyla 160 mg prašak za koncentrat za otopinu za infuziju trastuzumab emtanzin
English: Invasive Disease-Free Survival (IDFS) Number (%) of patients with event HR [95% CI] p-value (Log-Rank test, unstratified) 3 year event-free rate2,% [95% CI] Secondary Endpoints
Croatian: Primarni ishodi Preživljenje bez progresije bolesti (PFS) prema procjeni neovisnog ocjenjivačkog povjerenstva (IRC) Broj (%) bolesnika s događajem Medijan trajanja PFS-a (mjeseci) Omjer hazarda (stratificiran*) 95% CI za omjer hazarda p-vrijednost (Log-rang test, stratificiran*)
English: The use of 0.20 or 0.22 micron in-line polyethersulfone (PES) filter is required for the infusion when the concentrate for infusion is diluted with sodium chloride 9 mg/mL (0.9%) solution for infusion.
Croatian: Kada se koncentrat za infuziju razrijedi otopinom natrijeva klorida za infuziju od 9 mg/ml (0,9%), za primjenu infuzije potreban je polietersulfonski (PES) ugrađeni filtar od 0,20 ili 0,22 mikrometara.
English: Laboratory abnormalities
Croatian: Rekonstituirana otopina
English: peripheral neuropathy until resolution to ≤ Grade 2.
Croatian: Trastuzumab emtanzin ne smije se primijeniti dok se nuspojava ne ublaži do stupnja ≤ 2.
English: Reconstituted solution should be inspected visually for particulate matter and discolouration prior to administration.
Croatian: Prije primjene rekonstituirane otopine, potrebno je provjeriti moguću prisutnost čestica i promjenu boje.
English: Grade 4 (> 20 ´ ULN at any time)
Croatian: (> 20 × GGN u bilo kojem trenutku)
English: Grade 3 (> 3 to ≤ 10´ the ULN)
Croatian: (> 3 do ≤ 10 × GGN)
English: AST/ALT recovers to Grade ≤ 2, and then reduce one dose level
Croatian: Trastuzumab emtanzin ne smije se primijeniti dok se AST/ALT ne vrate na vrijednosti stupnja ≤ 2, a zatim dozu treba smanjiti za jednu razinu.
English: Musculoskeletal and connective tissue disorders
Croatian: Simptomatsko kongestivno zatajenje srca
English: STATEMENT OF ACTIVE SUBSTANCE(S) One vial of powder for concentrate for solution for infusion contains 100 mg of trastuzumab emtansine.
Croatian: Jedna bočica s praškom za koncentrat za otopinu za infuziju sadrži 100 mg trastuzumab emtanzina.
English: Succinic acid Sodium hydroxide Sucrose
Croatian: FARMACEUTSKI PODACI 6.1 Popis pomoćnih tvari sukcinatna kiselina natrijev hidroksid saharoza polisorbat 20
English: Hypersensitivity was reported in 2.7% of patients with EBC, with Grade 3 or 4 in 0.4% of patients.
Croatian: Preosjetljivost je prijavljena u 2,7% bolesnika s ranim rakom dojke, pri čemu su događaji stupnja 3 ili 4 zabilježeni u 0,4% bolesnika.Ukupno je većina reakcija preosjetljivosti bila blage do umjerene težine, a povukla se nakon liječenja.
English: Baseline patient and tumour characteristics were well balanced between treatment groups.
Croatian: Ispitivane skupine bile su dobro uravnotežene s obzirom na početne karakteristike bolesnika i tumora.
English: Moreover, the intended uses do not require medical supervision.
Croatian: Štoviše, predviđena uporaba ne zahtjeva liječnički nadzor.
English: Agrimony should only be used in adults and children over the age of 12 years.
Croatian: Turičina zelen smije se koristiti samo u odraslih i djece starije od 12 godina.
English: This means that, although there is insufficient evidence from clinical trials, the effectiveness of these herbal medicines is plausible and there is evidence that they have been used safely in this way for at least 30 years (including at least 15 years within the EU).
Croatian: To znači da, iako nema dovoljno dokaza iz kliničkih ispitivanja, učinkovitost ovih biljnih lijekova je vjerojatna te postoji dokaz o njihovoj sigurnoj uporabi na ovaj način tijekom najmanje 30 godina (uključujući najmanje 15 godina na području EU).
English: These may also be used to prepare liquid extracts with water and alcohol.
Croatian: Pripravci se također mogu koristiti za pripremu tekućih ekstrakata s vodom i alkoholom.
English: Agrimony
Croatian: Detaljne
English: It can also be applied to the skin for relief of minor inflammation and small superficial wounds.
Croatian: Može se također primijeniti na kožu za ublažavanje blage upale i malih površinskih rana.
English: What is agrimony?
Croatian: Što je turičina zelen?
English: This summary is not intended to provide practical advice on how to use medicines containing agrimony.
Croatian: Svrha ovog sažetka nije pružanje praktičnih savjeta o načinu uporabe lijekova koji sadrže turičinu zelen.
English: Agrimony preparations are obtained by comminuting (reducing into tiny pieces) the dried plant parts.
Croatian: Pripravci turičine zeleni dobivaju se usitnjavanjem (smanjivanjem u male komade) dijelova suhe biljke.
English: They are also available as liquids to be applied to the skin or used as a bath additive.
Croatian: Dostupni su i kao tekućine za primjenu na kožu ili za dodavanje u kupke.
English: The HMPC conclusions on the use of agrimony medicines for the relief of mild diarrhoea, mild inflammation of the mouth and throat, skin inflammation and wounds are based on their ‘traditional use' in these conditions.
Croatian: Zaključci HMPC-a o uporabi lijekova koji sadrže turičinu zelen za ublažavanje blagog proljeva, blage upale usta ili grla, upale kože i rana temelje se na "tradicionalnoj uporabi" u navedenim stanjima.
English: The HMPC noted the lack of clinical studies with agrimony, but took into account the well documented use of this herbal medicine for the above uses.
Croatian: HMPC je istaknuo nedostatak kliničkih ispitivanja s turičinom zeleni, no uzeo je u obzir dobro dokumentiranu primjenu ovog biljnog lijeka u prethodno navedenim primjenama.
English: Agrimony can also be found in combination with other herbal substances in some herbal medicines.
Croatian: Turičina zelen se može također naći i u kombinaciji s drugim biljnim tvarima u pojedinim biljnim lijekovima.
English: Further information on the HMPC assessment of agrimony medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Croatian: Dodatne informacije o HMPC-ovoj ocjeni lijekova koji sadrže turičinu zelen, uključujući pojedinosti zaključaka Povjerenstva, mogu se pronaći u rubrici 'All documents' na internetskoj stranici Agencije: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Further information on the risks associated with agrimony medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Croatian: Više informacija o rizicima povezanim s lijekovima koji sadrže turičinu zelen, uključujući odgovarajuće mjere opreza za njihovu sigurnu uporabu, nalazi se u monografiji u rubrici 'All documents' na internetskoj stranici Agencije: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: The HMPC concluded that, on the basis of its long-standing use, agrimony can be taken by mouth for the relief of mild diarrhoea, or used as a gargle to relieve mild inflammation of the mouth and throat.
Croatian: HMPC je zaključio da se, na temelju njegove dugotrajne uporabe, turičina zelen može kroz usta uzimati za ublažavanje blagog proljeva, ili se koristiti kao grgljača za ublažavanje blage upale usta i grla.
English: Any applications for the licensing of medicines containing agrimony have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Croatian: Svi zahtjevi za odobrenje lijekova koji sadrže turičinu zelen moraju se podnijeti nacionalnim tijelima nadležnim za lijekove, koja ocjenjuju zahtjev za biljni lijek i uzimaju u obzir znanstvene zaključke HMPC-a.
English: Information on the use and licensing of agrimony medicines in EU Member States should be obtained from the relevant national authorities.
Croatian: Informacije o uporabi i odobrenju lijekova koji sadrže turičinu zelen u državama članicama EU-a mogu se dobiti od nadležnih nacionalnih tijela.
English: Herbal medicines containing agrimony are usually available as herbal teas to be drunk, or as gargles.
Croatian: Biljni lijekovi koji sadrže turičinu zelen najčešće su dostupni kao biljni čajevi za piće ili kao grgljače.
English: treatment, or if mouth, throat or skin symptoms persist for more than a week during treatment.
Croatian: Ako se proljev nastavi dulje od 3 dana tijekom liječenja, ili ako se simptomi u ustima, grlu ili na koži nastave dulje od tjedan dana tijekom liječenja potrebno je konzultirati liječnika ili kvalificiranog zdravstvenog radnika.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing agrimony.
Croatian: Države članice Europske unije uzimaju u obzir zaključke HMPC-a prilikom ocjenjivanja zahtjeva za odobrenje biljnih lijekova koji sadrže turičinu zelen.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of agrimony.
Croatian: Ovaj dokument predstavlja sažetak znanstvenih zaključaka Povjerenstva za biljne lijekove (HMPC) u pogledu medicinske uporabe turičine zeleni.
English: What are the risks associated with agrimony medicines?
Croatian: Koji su rizici povezani s lijekovima koji sadrže turičinu zelen?
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
Croatian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom upute o načinu primjene lijekova koji sadrže turičinu zelen i tko ih može primjenjivati dostupne su u uputi o lijeku koja je priložena uz lijek.
English: Other information about agrimony medicines
Croatian: Ostale informacije o lijekovima koji sadrže turičinu zelen
English: For practical information about using agrimony medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Croatian: Za praktične informacije o uporabi lijekova koji sadrže turičinu zelen bolesnici trebaju pročitati uz lijek priloženu uputu o lijeku ili se obratiti svom liječniku ili ljekarniku.
English: What evidence supports the use of agrimony medicines?
Croatian: Koji dokazi potkrjepljuju uporabu lijekova koji sadrže turičinu zelen?
English: For more information about treatment with Agrimony medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekovima koji sadrže turičinu zelen pročitajte u uputi o lijeku priloženoj uz lijek odnosno obratite se svom liječniku ili ljekarniku.
English: Agrimony is the common name for the flowering tops of the plant Agrimonia eupatoria L. The plant is cultivated or gathered to obtain the plant parts for medicinal use.
Croatian: Turičina zelen je uobičajen naziv za cvjetne vrhove biljke Agrimonia eupatoria L.
English: How are agrimony medicines approved in the EU?
Croatian: Kako se unutar EU odobravaju lijekovi koji sadrže turičinu zelen?
English: Date of latest renewal: 18 September 2014
Croatian: Datum posljednje obnove: 18. rujna 2014.
English: Adults (including the elderly ≥ 65 years of age)
Croatian: Odrasli (uključujući osobe u dobi od ≥ 65 godina)
English: Some patients had more than one cause of pain.
Croatian: Neki su bolesnici imali više od jednog uzroka boli.
English: In addition, you may also occasionally experience muscular problems.
Croatian: Osim toga, povremeno možete osjetiti teškoće s mišićima.
English: The median exposure time was 43 days.
Croatian: Medijan vremena izloženosti bio je 43 dana.
English: However, in view of limited data, the development of tolerance cannot be excluded.
Croatian: Međutim, s obzirom na ograničene podatke, razvoj tolerancije se ne može isključiti.
English: The safety and efficacy of ziconotide in children aged 0 to 18 years have not been established.
Croatian: Sigurnost i djelotvornost zikonotida u djece u dobi od 0 do 18 godina nisu ustanovljene.
English: What Prialt is and what it is used for
Croatian: Što je Prialt i za što se koristi
English: There was no indication of respiratory depression.
Croatian: Nije bilo indikacija za respiratornu depresiju.
English: t½ (hr)
Croatian: t½ (h)
English: The patient usually remains conscious and breathing is not depressed.
Croatian: Bolesnik obično ostaje pri svijesti i disanje nije deprimirano.
English: The initial fill must therefore be replaced after 14 days.
Croatian: Stoga se početno punjenje mora zamijeniti nakon 14 dana.
English: In case of a need for long term treatment, monitoring may be necessary (as decided by your doctor).
Croatian: U slučaju potrebe za dugotrajnim liječenjem, možda je potreban nadzor (to će odlučiti Vaš liječnik).
English: At the start of your treatment your doctor may increase your dose every 1 to 2 days or more.
Croatian: Na početku liječenja liječnik Vam može povećavati dozu nakon 1 do 2 dana ili više.
English: SD - Standard Deviation.
Croatian: SD - standardna devijacija
English: Subsequently the pump should be emptied and refilled every 60 days.
Croatian: Kasnije, pumpu treba isprazniti i ponovno napuniti svakih 60 dana.
English: Other medicines and Prialt
Croatian: Drugi lijekovi i Prialt
English: Therefore, caution is needed during long-term treatment.
Croatian: Stoga je u dugotrajnom liječenju potreban oprez.
English: You must tell your doctor immediately if you experience any of the above symptoms.
Croatian: Odmah obavijestite svoga liječnika ako osjetite bilo koji od gore navedenih simptoma.
English: Depression of Central Nervous System (CNS)
Croatian: Depresija središnjeg živčanog sustava (SŽS)
English: The technical data are given only for information and should not limit health-care providers' choice.
Croatian: Tehnički podaci dani su samo informativno i ne smiju ograničavati izbor zdravstvenim djelatnicima.
English: The efficacy of IT ziconotide was apparent in all groups.
Croatian: Djelotvornost intratekalnog zikonotida bila je vidljiva u svim skupinama.
English: The biological activity of the various expected proteolytic degradation products has not been assessed.
Croatian: Biološka aktivnost različitih očekivanih proteolitičkih razgradnih produkata nije procjenjivana.
English: - You may experience drowsiness or may not be fully aware of your surroundings whilst receiving treatment.
Croatian: - Možda ćete se osjećati mamurno ili možda nećete biti potpuno svjesni svog okruženja tijekom primanja lijeka.
English: Therefore, pharmacological effects related to systemic exposure should be minimal.
Croatian: Dakle, farmakološki učinci u odnosu na sistemsku izloženost trebali bi biti minimalni.
English: Ask your doctor for advice before you drive or operate machinery.
Croatian: Pitajte za savjet liječnika prije upravljanja vozilima ili strojevima.
English: CL = clearance; Vd = distribution volume; t½ = half life
Croatian: CL = klirens; Vd = volumen distribucije; t½ = poluvijek
English: An external catheter system should only be used when an internal system cannot be implanted.
Croatian: Vanjski kateterski sustav treba upotrijebiti samo onda kada nije moguće ugraditi unutarnji sustav.
English: These results do not indicate a significant risk to humans due to the relatively high systemic exposures needed to elicit these effects in rats and rabbits.
Croatian: Ti rezultati ne pokazuju značajan rizik za ljude zbog relativno visokih sistemskih izlaganja potrebnih da bi se takvi učinci pojavili u štakora i kunića.
English: Specific instructions for using the pumps must be obtained from the manufacturer.
Croatian: Posebne upute za uporabu pumpi mora dostaviti proizvođač.
English: Your doctor will discuss with you the kind of pump that will be most suitable for you and when you need to have your pump refilled.
Croatian: Liječnik će s Vama razmotriti koja je vrsta pumpe za Vas najprikladnija i kada je pumpu potrebno ponovno napuniti.
English: If you receive more Prialt than you should
Croatian: Ako primite više lijeka Prialt nego što ste trebali
English: It is an N-type calcium channel blocker (NCCB).
Croatian: On je blokator kalcijevih kanala N-tipa (NCCB).
English: Respondera n (%)
Croatian: Bolesnici s odgovoroma n (%)